Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MT-CO2 | P00403 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 4/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL516526 | 0.95 | MT-CO2 (0.40) | MT-CO2ALDH1A1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL7927992 | 0.93 | MT-CO2 (0.46) | MT-CO2ALDH1A1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL13148722 | 0.93 | MT-CO2 (0.46) | MT-CO2ALDH1A1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL922803 | 0.93 | MT-CO2 (0.46) | MT-CO2ALDH1A1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL21401590 | 0.92 | MT-CO2 (0.47) | MT-CO2ALDH1A1RAB9AL3MBTL1CYP2C9 | |
| SCHEMBL28440815 | 0.87 | ATM (0.46) | MT-CO2NPC1RAB9ASMN1; SMN2RECQL | |
| SCHEMBL12606469 | 0.87 | MT-CO2 (0.44) | MT-CO2ALDH1A1L3MBTL1CYP2C9CYP2C19 | |
| SCHEMBL7930497 | 0.86 | MT-CO2 (0.41) | MT-CO2ALDH1A1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL7929176 | 0.84 | RAB9A (0.50) | MT-CO2ALDH1A1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL16523071 | 0.84 | KDM4E (0.40) | MT-CO2ALDH1A1NPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120024382-A1 | NOVEL COMPOUNDS, DERIVATIVES THEREOF AND THEIR USE IN HETEROJUNCTION DEVICES | THE UNIVERSITY OF ULM (DE) | 2012-02-02 | — | — | US | disclosed |
| US-20120024382-A1 | NOVEL COMPOUNDS, DERIVATIVES THEREOF AND THEIR USE IN HETEROJUNCTION DEVICES | THE UNIVERSITY OF ULM (DE) | 2012-02-02 | — | — | US | disclosed |
| US-20120024382-A1 | NOVEL COMPOUNDS, DERIVATIVES THEREOF AND THEIR USE IN HETEROJUNCTION DEVICES | THE UNIVERSITY OF ULM (DE) | 2012-02-02 | — | — | US | disclosed |
| US-20080039581-A1 | Triarylamine Compounds, Compositions and Devices | MERCK PATENT GMBH (DE) | 2008-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120024382-A1 | NOVEL COMPOUNDS, DERIVATIVES THEREOF AND THEIR USE IN HETEROJUNCTION DEVICES | DDT, DCX, PIN1 | MT-CO2 2791/4885ALDH1A1 1940/4885NPC1 1742/4885 |
| US-20080039581-A1 | Triarylamine Compounds, Compositions and Devices | RER1, F3, PRMT1 | MT-CO2 2795/4885ALDH1A1 980/4885NPC1 1624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.